NCT00742963 2025-05-13Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue SarcomaImmunoGenesisPhase 1/2 Completed107 enrolled 7 charts
NCT02255110 2018-12-14A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue SarcomaMerck KGaA, Darmstadt, GermanyPhase 2 Terminated6 enrolled 6 charts